---

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

---

 

Form 8-K

 

---

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

July 19, 2004 (Date of earliest event reported)

 

Commission File Number 000-19627

 

---

 

BIOLASE TECHNOLOGY, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

---

 

Delaware		000-19627		87-0442441
(State or Other Jurisdiction of Incorporation or Organization)		(Commission file number)		(I.R.S. Employer Identification No.)

 

981 Calle Amanecer

San Clemente, California 92673

(Address of Principal Executive Offices, Including Zip Code)

 

(949) 361-1200

(Registrant’s Telephone Number, Including Area Code)

 

---

---

Item 5. Other Events and Regulation FD Disclosure.

 

On July 19, 2004, BioLase Technology, Inc. issued a press release announcing its Board of Directors has authorized a 1.25 million share repurchase program. A copy of the press release is attached herewith as Exhibit 99.1.

 

Item 7. Financial Statements and Exhibits.

 

(c) Exhibits.

 

99.1     Press Release, dated July 19, 2004.

 

2

---

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: July 20, 2004		BIOLASE TECHNOLOGY, INC.,
		(Registrant)
		By:		/s/ EDSON J. ROOD
				Edson J. Rood
				Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

 

3